A review of the treatment of primary headaches. Part I: Migraine
- 1 November 1995
- journal article
- review article
- Published by Springer Nature in The Italian Journal of Neurological Sciences
- Vol. 16 (8) , 577-586
Abstract
Finding the best treatment for a patient's migraine is often a problem in clinical practice since the condition is very common, often debilitating and may prove refractory to therapy. Over recent years, more effective migraine treatments have been found and validated, and the traditional remedies have undergone controlled testing. This article reviews the various therapies available for both the acute treatment and prevention of migraine. Treatments often effective against migraine attacks are: aspirin, analgesics, non steroid antiinflammatory drugs (NSAIDs), ergot derivatives and sumatriptan. Five main classes of prophylactic drug are currently used: beta-blockers, calcium antagonists, serotonin modulators, NSAIDs and ergot compounds. Biofeedback, one of the most efficacious non-pharmacological preventive treatments of migraine, is also discussed.Keywords
This publication has 43 references indexed in Scilit:
- Headaches in patients with brain tumorsNeurology, 1993
- CP‐93,129, sumatriptan, dihydroergotamine block c‐fos expression within rat trigeminal nucleus caudalis caused by chemical stimulation of the meningesBritish Journal of Pharmacology, 1992
- Double Blind Comparison of Lithium and Verapamil in Cluster Headache ProphylaxisHeadache: The Journal of Head and Face Pain, 1990
- The antimigraine drug, sumatriptan (GR43175), selectively blocks neurogenic plasma extravasation from blood vessels in dura materBritish Journal of Pharmacology, 1990
- The Classification of Calcium Antagonists by the WHO Expert Committee: Relevance in NeurologyCephalalgia, 1988
- MigraineArchives of Neurology, 1987
- Successful migraine prophylaxis with naproxen sodiumNeurology, 1985
- Amitriptyline in Migraine ProphylaxisArchives of Neurology, 1979
- Temperature Biofeedback in the Treatment of Migraine HeadachesArchives of General Psychiatry, 1978
- Prophylactic and Therapeutic Properties of 1-Methyl-Lysergic Acid Butanolamide in MigraineInternational Archives of Allergy and Immunology, 1959